Your body produces thousands of different peptides, each with a specific function
IGF-1 LR3 is modified at two positions (N-terminal 13-amino-acid extension and Arg3 substitution) to substantially reduce IGFBP-3 binding, extending preclinical activity duration well beyond the roughly 10 to 12 minutes seen with unbound native IGF-1
The interday was determined by preparing standard and placebo sample at a concentration of 0.005 mg/ml on different days and on different instrument (Agilent 1100 series system, Santa Clara, CA, USA, comprised of a quaternary pump solvent delivery module)
Manufactured in a GMP-compliant, FSSAI-certified facility for third-party manufacturing, contract manufacturing, private labeling, and international bulk exports
Users can trust in the reliability and safety of the product, knowing that it has been tested and approved by dermatologists